Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
Eli Lilly and Company
Eli Lilly and Company
Dartmouth-Hitchcock Medical Center
Karyopharm Therapeutics Inc
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
Calithera Biosciences, Inc
Ohio State University Comprehensive Cancer Center
California Cancer Consortium
Massachusetts General Hospital
Amgen
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
Cellerant Therapeutics
Indiana University
Rutgers, The State University of New Jersey
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
Northwestern University
Vertex Pharmaceuticals Incorporated
Mayo Clinic
NYU Langone Health
University of Arizona
Rutgers, The State University of New Jersey